Physician

Michael Gene Valpiani, M.D.

According to 2025 Medicare claims, Michael Valpiani, M.D. (NPI: 1346235355) practices interventional pain management (ipm) in the Lake Havasu City-Kingman, AZ market, with the plurality of this provider's patient population coming from Mohave, AZ. This provider's primary affiliated billing organization is MICHAEL G VALPIANI MD AZ LTD (NPI: 1902191992; TIN: 743137943) and primary practice location at 77429-1108.

Valpiani's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 347 traditional Medicare patients, billed 5,675 HCPCS/CPT codes, and received $486,047 in Medicare payments. The top billing code was G0483 (Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms). Part D data shows 5,595 prescription claims across 394 beneficiaries totaling $195,624 in drug costs, led by Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $273,342 to $486,047. In contrast, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $734,756 to $195,624. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	417	4,939	$273,342
2016	524	6,384	$327,551
2017	446	4,976	$289,463
2018	407	4,087	$245,348
2019	341	2,988	$220,364
2020	260	3,519	$282,665
2021	291	9,701	$355,485
2022	1,086	18,331	$525,766
2023	268	6,064	$359,684
2024	347	5,675	$486,047

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	546	10,236	$734,756
2016	626	11,151	$777,898
2017	557	9,395	$628,818
2018	490	6,840	$344,250
2019	434	6,091	$300,043
2020	368	5,407	$214,220
2021	343	5,163	$196,471
2022	315	4,436	$161,276
2023	395	5,110	$171,525
2024	394	5,595	$195,624

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms	249	697	$241
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms	133	183	$153
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	174	1,627	$86
80307	Testing for presence of drug, by chemistry analyzers	262	891	$61
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	35	35	$54

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	754	22,100	$32,765
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	1,002	29,233	$29,581
Oxycodone Hcl	Oxycodone Hcl	1,050	30,808	$25,191
Oxycontin	Oxycodone Hcl	29	866	$18,136
Lyrica	Pregabalin	19	541	$14,040

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Michael Gene Valpiani, M.D.?

Tedicare shows public-source Medicare data for Michael Gene Valpiani, M.D. (NPI 1346235355), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael Gene Valpiani, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Michael Gene Valpiani, M.D.?

Michael Gene Valpiani, M.D. is linked to MICHAEL G VALPIANI MD AZ LTD (billing NPI 1902191992) in the available physician profile data.

Does Michael Gene Valpiani, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.